These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34087565)

  • 1. A purified inactivated vaccine derived from Vero cell-adapted zika virus elicits protection in mice.
    Oh HS; Yoon JW; Lee S; Kim SO; Hong SP
    Virology; 2021 Aug; 560():124-130. PubMed ID: 34087565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice.
    Baldwin WR; Livengood JA; Giebler HA; Stovall JL; Boroughs KL; Sonnberg S; Bohning KJ; Dietrich EA; Ong YT; Danh HK; Patel HK; Huang CY; Dean HJ
    Sci Rep; 2018 Nov; 8(1):16509. PubMed ID: 30405178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus Vector-Based Vaccines Confer Maternal-Fetal Protection against Zika Virus Challenge in Pregnant IFN-αβR
    Larocca RA; Mendes EA; Abbink P; Peterson RL; Martinot AJ; Iampietro MJ; Kang ZH; Aid M; Kirilova M; Jacob-Dolan C; Tostanoski L; Borducchi EN; De La Barrera RA; Barouch DH
    Cell Host Microbe; 2019 Nov; 26(5):591-600.e4. PubMed ID: 31668877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.
    Ye X; Liu X; Shu T; Deng W; Liao M; Zheng Y; Zheng X; Zhang X; Li T; Fan W; Qu L; Chen L; Li F; Feng L
    J Virol; 2021 Jun; 95(14):e0038321. PubMed ID: 33910950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine.
    In HJ; Lee YH; Jang S; Lim HJ; Kim MY; Kim JA; Yoo JS; Chung GT; Kim YJ
    Virology; 2020 Oct; 549():25-31. PubMed ID: 32818729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immune responses against a lethal Zika virus challenge post-vaccination with a dual serotype of recombinant vesicular stomatitis virus carrying the genetically modified Zika virus E protein gene.
    Choi JA; Wu K; Kim GN; Saeedian N; Seon SH; Park G; Jung DI; Jeong HW; Kim NH; Seo SH; Lee S; Song M; Kang CY
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NS1-based DNA vaccination confers mouse protective immunity against ZIKV challenge.
    Zhan Y; Pang Z; Du Y; Wang W; Yang Y; Wang W; Gao GF; Huang B; Deng Y; Tan W
    Infect Genet Evol; 2020 Nov; 85():104521. PubMed ID: 32882433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.
    Tai W; He L; Wang Y; Sun S; Zhao G; Luo C; Li P; Zhao H; Fremont DH; Li F; Jiang S; Zhou Y; Du L
    Emerg Microbes Infect; 2018 Jan; 7(1):7. PubMed ID: 29362446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.
    Tebas P; Roberts CC; Muthumani K; Reuschel EL; Kudchodkar SB; Zaidi FI; White S; Khan AS; Racine T; Choi H; Boyer J; Park YK; Trottier S; Remigio C; Krieger D; Spruill SE; Bagarazzi M; Kobinger GP; Weiner DB; Maslow JN
    N Engl J Med; 2021 Sep; 385(12):e35. PubMed ID: 34525286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
    Lecouturier V; Bernard MC; Berry C; Carayol S; Richier E; Boudet F; Heinrichs J
    Vaccine; 2019 May; 37(20):2679-2686. PubMed ID: 30967310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection.
    Yau C; Gan ES; Kwek SS; Tan HC; Ong EZ; Hamis NZ; Rivino L; Chan KR; Watanabe S; Vasudevan SG; Ooi EE
    EBioMedicine; 2020 Nov; 61():103028. PubMed ID: 33045466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine protection against Zika virus from Brazil.
    Larocca RA; Abbink P; Peron JP; Zanotto PM; Iampietro MJ; Badamchi-Zadeh A; Boyd M; Ng'ang'a D; Kirilova M; Nityanandam R; Mercado NB; Li Z; Moseley ET; Bricault CA; Borducchi EN; Giglio PB; Jetton D; Neubauer G; Nkolola JP; Maxfield LF; De La Barrera RA; Jarman RG; Eckels KH; Michael NL; Thomas SJ; Barouch DH
    Nature; 2016 Aug; 536(7617):474-8. PubMed ID: 27355570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates.
    Medina LO; To A; Lieberman MM; Wong TAS; Namekar M; Nakano E; Andersen H; Yalley-Ogunro J; Greenhouse J; Higgs S; Huang YS; Vanlandingham DL; Horton JS; Clements DE; Lehrer AT
    Front Immunol; 2018; 9():2464. PubMed ID: 30467501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.